AFP and hepatocellular carcinoma: EASL and DGVS guidelines for HBV and HCC recommend HCC screening by abdominal ultrasound every six months with the optional determination of alpha-fetoprotein in chronic HBV patients with enhanced HCC risk (patients with advanced fibrosis or cirrhosis) [13,25].